Skip to main content
Clinical Trials/NCT06365957
NCT06365957UnknownNot Applicable

Acute Changes in Cardiometabolic and Neurocognitive Outcomes in Response to Exercise Combined With Ketone Ester Supplement in Overweight/Obese Adults

University of Macau0 sites20 target enrollmentStarted: April 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
20
Primary Endpoint
Diastolic Blood Pressure

Study Overview

Brief Summary

To examine the acute changes in cardiometabolic and neurocognitive outcomes in response to exercise combined with ketone ester supplement in overweight/obese adults.

Detailed Description

The prevalence of excess body weight and associated medical burdens (i.e., cardiometabolic and neurocognitive impairments) have been rising over the past several decades globally. The combination of exercise and ketone supplementation has been recently proposed as one of the solutions with potential clinical value, of which the interventional effects and underlying mechanisms remain unclear. The current study aims at (1) investigating the additive effects of ketone ester supplements to exercise in aspects of cardiorespiratory fitness, metabolism, and neurocognitive status, and (2) examining how the exercise type (HIIE [high-intensity interval exercise] vs. MICE [moderate-intensity continuous exercise]) influences the cardiometabolic and neurocognitive responses of the exercise-diet regime. For each of the 30 participants, six experimental trials will be performed in a randomized trial with a counterbalanced order: (1) HIIE-KT condition (HIIE with ketone supplements); (2) MICE-KT condition (MICE with ketone supplements); (3) NE-KT condition (non-exercise with ketone supplements); (4) HIIE-PLA condition (HIIE with taste-matched placebo); (5) MICE-PLA condition; and (6) NE-PLA condition. Cardiometabolic and neurocognitive parameters will be assessed before and after 30, 60, and 90 min subsequently ketone ester supplements.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •body mass index > 25 kg/m^2;
  • •right-handed.

Exclusion Criteria

  • •psychiatric, neurologic, cardiovascular, or metabolic disease, including type 1 and type 2 diabetes mellitus;
  • •addicts to alcohol, nicotine, or drugs;
  • •oral contraceptive or any medication intake during the past 6 months;
  • •current engagement in any resistant exercise.

Arms & Interventions

High-intensity interval exercise (HIIE)-Ketone Supplementation (KT) condition

Experimental

High-intensity interval exercise (HIIE) with ketone supplements [R-1,3-butanediol; San Francisco].

Intervention: Ketone monoester supplementation (Other)

High-intensity interval exercise (HIIE)-Ketone Supplementation (KT) condition

Experimental

High-intensity interval exercise (HIIE) with ketone supplements [R-1,3-butanediol; San Francisco].

Intervention: High-intensity interval exercise (Other)

MICE-KT condition

Experimental

moderate-intensity continuous exercise (MICE) with ketone supplements.

Intervention: Ketone monoester supplementation (Other)

MICE-KT condition

Experimental

moderate-intensity continuous exercise (MICE) with ketone supplements.

Intervention: Moderate-intensity continuous exercise (Other)

Nonexercise (NE)-KT condition

Experimental

Non-exercise with ketone supplements.

Intervention: Ketone monoester supplementation (Other)

HIIE-Placebo (PLA) condition

Experimental

HIIE with taste-matched placebo

Intervention: High-intensity interval exercise (Other)

HIIE-Placebo (PLA) condition

Experimental

HIIE with taste-matched placebo

Intervention: Placebo (Other)

MICE-PLA condition

Experimental

MICE with taste-matched placebo

Intervention: Moderate-intensity continuous exercise (Other)

MICE-PLA condition

Experimental

MICE with taste-matched placebo

Intervention: Placebo (Other)

NE-PLA condition

Experimental

Non-exercise with taste-matched placebo

Intervention: Placebo (Other)

Outcomes

Primary Outcomes

Diastolic Blood Pressure

Time Frame: 6 weeks

The measurement name is "diastolic blood pressure". It will be assessed by a blood pressure monitor in laboratory settings. The unit of measurement is millimeters of mercury (mmHg).

Systolic Blood Pressure

Time Frame: 6 weeks

The measurement name is "systolic blood pressure". It will be assessed by a blood pressure monitor in laboratory settings. The unit of measurement is millimeters of mercury (mmHg).

Accuracy of N-back Task

Time Frame: 6 weeks

The measurement name is "accuracy of N-back task". The measurement will be assessed by psychological paradigm named N-back task. Accuracy is generally measured as a percentage (%).

Concentration of Blood Glucose

Time Frame: 6 weeks

The measurement name is "blood glucose". It will be assessed by a glucometer in laboratory settings. The unit of measurement is millimoles per liter (mmol/L).

Reaction Time of N-back Task

Time Frame: 6 weeks

The measurement name is "reaction time of N-back task". The measurement will be assessed by psychological paradigm named N-back task. The unit of measurement is milliseconds (ms).

Cerebral Hemoglobin Concentration

Time Frame: 6 weeks

The measurement name is "cerebral hemoglobin concentration". The measurement will be assessed by functional near-infrared spectroscopy (fNIRS). The unit of measurement is micromoles per liter (μM).

Maximal Oxygen Uptake

Time Frame: 2 weeks

The measurement name is "maximal oxygen uptake". It will be assessed by cardiopulmonary exercise testing (CPET) equipment, such as cycle ergometers, along with a metabolic cart for measuring oxygen consumption. The unit of measurement is milliliters of oxygen per kilogram per minute(mL/kg/min).

Concentration of Blood Lipid

Time Frame: 6 weeks

The measurement name is "blood lipid". It will be assessed by the cholestene system in laboratory settings. The unit of measurement is milligrams per deciliter (mg/dL).

Concentration of Blood Beta-Hydroxybutyrate

Time Frame: 6 weeks

The measurement name is "blood beta-hydroxybutyrate". It will be assessed by specific ketone meters designed for beta-hydroxybutyrate measurement. The unit of measurement is millimoles per liter (mmol/L).

Concentration of Blood Lactic Acid

Time Frame: 6 weeks

The measurement name is "blood lactic acid". It will be assessed by lactate monitor in laboratory settings. The unit of measurement is millimoles per litre (mmol/L).

Concentration of Blood Insulin

Time Frame: 6 weeks

The measurement name is "blood insulin". It will be assessed by immunoassay system (chemiluminescence immunoassay analyzer) using blood samples. The unit of measurement is microunits per milliliter (μU/mL).

Reaction Time of Stroop Task

Time Frame: 6 weeks

The measurement name is "reaction time of stroop task". The measurement will be assessed by psychological paradigm named Stroop Task. The unit of measurement is milliseconds (ms).

Accuracy of Stroop Task

Time Frame: 6 weeks

The measurement name is "accuracy of Stroop task". The measurement will be assessed by psychological paradigm named Stroop Task. Accuracy is generally measured as a percentage (%).

Secondary Outcomes

  • Arousal Level(6 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials